Navigation Links
Research Shows That SurePure Technology Offers Alternative to Thermal Pasteurization of Human Breast Milk
Date:7/9/2013

NEW YORK, July 9, 2013 /PRNewswire/ -- SurePure, Inc. (OTCBB:SURP), a global leader in liquid photopurification, today announced that its proprietary photopurification technology has proven to be a viable alternative to the thermal pasteurization of human milk for milk banks in hospitals.

In research conducted at the Hartmann Human Lactation Research Group at the University of Western Australia, SurePure's photopurification technology delivered comparable microbiological purification without affecting essential enzymes and proteins. These enzymes and proteins include bile salt stimulated lipase (BSSL), alkaline phosphatase (AP), secretory IgA , lactoferrin, lysozyme, and are critical for the optimal development of neonates, especially amongst significantly premature infants.

Using a small trial unit, a simple adaptation of SurePure's commercial beverage-processing technology which has yet to be optimized for medical application, the equipment achieved 5-log reduction of total bacterial count. After small modifications of the unit it became possible to reduce the bacterial count to an undetectable (<5CFU/ml) level. More importantly the enzyme and protein work showed significant promise, with lipase retention of 100%, alkaline phosphatase retention of 100%, lysozyme of 75%, sIgA at 89%, lactoferrin at 87%, and no change in the bacteriostatic properties of fatty acids.

Says Steve Miller, VP Sales & Marketing at SurePure, "We are delighted with these preliminary results on human breast milk. This data is further evidence of the efficacy and safety of our unique photosterilization technology. After achieving solid results processing animal blood plasma, the results of this research evidences the untapped R&D and commercial potential of the technology in the medical and pharmaceutical arenas."

The full research can be accessed by clicking on
http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0068120

About SurePure

SurePure is a global leader in liquid photopurification, the green alternative to pasteurization and chemicals. Using its patented 'Turbulator' technology, SurePure systems use UV-C light to purify microbiologically sensitive liquids such as wine, fruit juice and milk. Although designed to deliver food-grade solutions, it can also be harnessed to improve processing liquids such as water, brines and sugar syrup solutions, even animal blood plasma. SurePure's technology offers greater microbiological efficacy than conventional UV systems and is effective for both clear and turbid liquids, a world first. SurePure offers a greener alternative to comparable heat or chemical-based processes and significant process and energy savings. It also provides opportunities for the development of innovative and differentiated products with desired consumer benefits, guaranteed food safety and sound commercial benefits. Go to www.surepureinc.com for more information.


'/>"/>
SOURCE SurePure, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Wolters Kluwer Research Now Available via Bloomberg Tradebook
2. ACORN Research, LLC Announces Partnership with AdeptBio, LLC
3. New England Biolabs Introduces Polbase, an Information Repository of Scientific Data for Polymerase Researchers
4. Researching graphene nanoelectronics for a post-silicon world
5. In new quantum-dot LED design, researchers turn troublesome molecules to their advantage
6. BBVA Foundation Unites the Efforts of Massachusetts General Hospital and Barcelonas Vall dHebron Hospital in Biomarker Research for Personalized Cancer Therapies
7. New research points to benefits of innovative cobas® HPV test for primary screening as Englands cervical cancer screening programme includes the test in current HPV "triage" rollout
8. Multidisciplinary team of researchers develop world’s lightest material
9. K computer research results awarded ACM Gordon Bell Prize
10. ResearchMoz: Ophthalmic Devices Market to 2017 - Glaucoma and Cataract Surgery Devices, Minimally Invasive Procedures in Ophthalmic Surgery to Drive the Ophthalmic Surgery Market
11. Researchers shrink tumors and minimize side effects using tumor-homing peptide to deliver treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica delle Marche in ... peritoneal or pleural mesothelioma. Their findings are the subject of a new article on ... biomarkers are signposts in the blood, lung fluid or tissue of mesothelioma patients that ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... MONICA, Calif. , June 23, 2016  The Prostate Cancer Foundation ... pioneer increasingly precise treatments and faster cures for prostate cancer. Members of the ... institutions across 15 countries. Read More About the Class ... ... ...
(Date:6/23/2016)... ... ... STACS DNA Inc., the sample tracking software company, today announced that Dr. Hays ... DNA as a Field Application Specialist. , “I am thrilled that Dr. Young ... DNA. “In further expanding our capacity as a scientific integrator, Hays brings a wealth ...
Breaking Biology Technology:
(Date:4/26/2016)... 27, 2016 Research and ... Biometrics Market 2016-2020"  report to their offering.  , ... The analysts forecast the global multimodal biometrics ... during the period 2016-2020.  Multimodal biometrics ... such as the healthcare, BFSI, transportation, automotive, and ...
(Date:4/14/2016)... 14, 2016 BioCatch ™, ... today announced the appointment of Eyal Goldwerger ... Goldwerger,s leadership appointment comes at a time ... the deployment of its platform at several of the ... which discerns unique cognitive and physiological factors, is a ...
(Date:3/29/2016)... 29, 2016 LegacyXChange, Inc. (OTC: ... and SelectaDNA/CSI Protect are pleased to announce our successful ... a variety of writing instruments, ensuring athletes signatures against ... collectibles from athletes on LegacyXChange will be assured of ... DNA. Bill Bollander , CEO states, ...
Breaking Biology News(10 mins):